| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,590 |
1,295 |
$1.03M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
14,303 |
4,868 |
$634K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
816 |
719 |
$188K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,190 |
1,321 |
$85K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,593 |
605 |
$60K |
| 27096 |
|
90 |
73 |
$52K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
214 |
187 |
$51K |
| 80053 |
Comprehensive metabolic panel |
2,764 |
2,419 |
$49K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,509 |
531 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
124 |
123 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,752 |
2,393 |
$13K |
| 64635 |
|
15 |
13 |
$12K |
| 62321 |
|
18 |
13 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
621 |
594 |
$9K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,941 |
1,654 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,382 |
2,080 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
291 |
264 |
$6K |
| 64450 |
|
17 |
12 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
266 |
245 |
$5K |
| 80061 |
Lipid panel |
178 |
162 |
$5K |
| 64636 |
|
26 |
13 |
$5K |
| A9270 |
Non-covered item or service |
314 |
157 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
91 |
85 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19 |
17 |
$2K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
67 |
59 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,644 |
1,393 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
160 |
149 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
893 |
797 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
282 |
240 |
$1K |
| 86140 |
|
103 |
97 |
$714.82 |
| 81003 |
|
195 |
181 |
$548.95 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
35 |
30 |
$377.50 |
| 85652 |
|
101 |
94 |
$339.57 |
| 83690 |
|
81 |
77 |
$297.56 |
| 90674 |
|
45 |
37 |
$212.20 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
32 |
29 |
$78.78 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68 |
64 |
$45.65 |
| 82150 |
|
12 |
12 |
$41.75 |
| 83735 |
|
47 |
40 |
$7.30 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
68 |
66 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42 |
37 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
95 |
83 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
64 |
54 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
52 |
48 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26 |
24 |
$0.00 |
| J3490 |
Unclassified drugs |
215 |
173 |
$0.00 |
| 84484 |
|
35 |
27 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
145 |
138 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
27 |
27 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
17 |
13 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
27 |
27 |
$0.00 |